Ajax-Loading

WuXi Biologics - Ebit

WuXi Biologics's Fiscal Year is From January To December - All Figures are in CNY, Billions.

The item "Ebit" stands at 5.90 Billion Chinese Yuans for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 09/30/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 70.91 percent compared to the value the year prior.
The 1 year change in percent is 70.91.
The 3 year change in percent is -2.06.
The 5 year change in percent is 423.53.
The 10 year change in percent is 7,397.36.

The Serie's long term average value is 2.35 Billion Chinese Yuans. It's latest available value, on 06/30/2025, is 150.46 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2014, to it's latest available value, on 06/30/2025, is +8,542.73%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 06/30/2025, is -2.06%.

Ebit for Related Companies:

LogoNameMarket Cap (USD)
LogoThermo Fisher Scientific Inc - Ebit215,194,320,896.00
LogoAgilent Technologies Inc - Ebit41,246,478,336.00
LogoWuXi AppTec Co Ltd - Ebit38,655,022,911.83
LogoIQVIA Holdings Inc - Ebit38,462,255,104.00
LogoMettler-Toledo International Inc - Ebit29,144,758,272.00